monocytes and lymphocytes. Monocytes differentiate into macrophages, the principal inflammatory cell constituent of the atherosclerotic plaque. 4 Macrophages may themselves contribute to the destabilization of the plaque by their secretion of metalloproteinases that degrade the fibrous cap separating the lipid-rich core from the arterial lumen. A strong correlation exists between macrophage plaque infiltration and ischemic symptoms, with this association persisting for several months after becoming symptomatic. 5 Numerous validation studies have proven 18 F-fluorodeoxyglucose (FDG), a glucose analog that accumulates in cells with a high glycolytic rate, to be the most robust positron emission tomographic (PET) tracer with which to image plaque inflammation. 6 FDG-PET/computed tomographic (CT) imaging is therefore a reliable and reproducible measure of vascular inflammation and provides valuable prognostic data. 7, 8 As the plaque size increases, oxygen levels deep within the plaque diminish, local hypoxia ensues, and microvessel formation from adventitia is triggered. Abnormal vascular development, characterized by leaky immature endothelial vessels, can lead to intraplaque hemorrhage, which promotes the transition from a stable to vulnerable plaque. This process may therefore predict future clinical outcomes. 9, 10 Novel noninvasive imaging modalities capable of detecting neovascularization include carotid contrast-enhanced ultrasound (CEUS). This promising imaging tool detects IPN with a good histological correlation. 11, 12 One advantage of this technique is that the ultrasound contrast media is purely intravascular, and its tissue uptake therefore reflects the total number of microvessels, rather than permeability of the activated endothelium. Furthermore, IPN as assessed by CEUS has been associated with past ischemic neurological events.
12 Figure 1 . Quantification of the area percentage of CD68 staining on digitized immunohistochemically stained slides by using a computerassisted planimetry. For each slice (A), the software identified the immunohistochemical staining to be quantified by minimizing background-staining artifacts using image filters (B). Macrophage staining was reported as a percentage (in this example: 7.16%) of the total plaque area (C). The box indicates the region corresponding to the high-powered CD68 stain (D). FC indicates fibrous cap; L, lumen; and NC, necrotic core.
Although a pathophysiologic link exists between the presence of inflamed cells and the triggering of neoangiogenesis, the temporal association between inflammation and neovascularization within the plaque has yet to be firmly established. Therefore, the aim of this study was to systematically assess the presence of inflammation and neovascularization using FDG-PET/CT and CEUS, respectively, in a population of consecutive asymptomatic and symptomatic patients scheduled for carotid surgery. Imaging findings were then systematically compared with histology.
Methods

Patient Recruitment and Study Protocol
Patients referred for carotid endarterectomy were prospectively recruited for this study. After obtaining written informed consent and completing a baseline questionnaire, patients were invited to attend a same-day combined assessment of carotid plaque inflammation by 18 F-FDG PET/ CT, and carotid IPN by CEUS. Imaging was performed by a physician blinded to the patient's history and with a maximal delay of 72 hours from the carotid surgery. The inclusion criteria were as follows: age >18 years, >70% carotid stenosis as determined by duplex ultrasound, and computed tomographic angiography. The indication for surgery was based on the referring physician's decision. The exclusion criteria were pregnancy, inability to provide informed consent, and a known allergy to sulfur-containing drugs. Both asymptomatic and symptomatic patients were recruited. Symptoms were defined as a carotid-territory-related transient ischemic attack or stroke within 6 months of imaging. The study protocol was approved by the ethical committee of our institution and was conducted in the Cliniques Universitaires Saint-Luc, which obtained full Association for the Accreditation of Human Research Protection Programs accreditation for clinical research in 2015.
F-FDG-PET/CT Imaging Protocol and Analyses
After a fasting period of >6 hours, patients received an intravenous injection of 300±20 MBq of 18 F-FDG. Imaging was performed after a circulation time of 150±22 minutes. The patient's head was secured in a head-holder, with arms placed to either side. Images were acquired using a Gemini PET/CT system (Philips Healthcare, The Netherlands). The patients breathed normally while CT imaging was performed with a 16-slice multidetector scanner (adaptive dose in Z-DOM mode; voltage, 120 kV; rotation, 500 ms; pitch, 0.813). One 15-minute bed position PET image (voxel size 2×2×2 mm 3 ) of the neck was obtained with the 3-dimensional (3D) mode and iterative reconstruction (3D line of response time-of-flight algorithm; Philips Healthcare) using CT-based attenuation correction, random, and scatter corrections. Patients were kept in a quiet environment before and after injection.
On the basis of anatomic boundaries defined by CT, carotid FDG uptake was measured at 2-mm intervals along the long axis of the carotid artery within a region of 6 mm above and below the bifurcation point. At each axial cross section, a single region of interest was drawn around the wall of the common or the internal carotid artery, and the maximum standardized uptake value measured. Standardized uptake value is the decay-corrected tissue concentration of FDG (kBq/mL) divided by the injected dose per body weight (kBq/g). Background Figure 2 . CD34 quantification. Each section was examined using a grid (A) to ensure coverage of the entire area of the section. Vasa vasora were identified by CD34-positive immunostaining (*) and were counted at a magnification of ×20 (the box indicates the region corresponding to the high-powered CD34 stain, B and C). Values are presented as mean±SD or n (%) or as median with interquartile range.
FDG-uptake was measured within the internal jugular vein on 4 consecutive cross sections. Target:background ratio (TBR) was calculated by dividing the carotid plaque maximum standardized uptake value by the venous blood maximum standardized uptake value.
Plaque calcium score was evaluated by the Agatston method on an independent workstation (Osirix v5.7; Geneva, Switzerland). A calcified plaque was defined as a radiation-attenuating structure above an attenuation threshold of 130 HU. The same region of interests that we used for PET analysis were used for the calcium score.
Carotid Ultrasonography, Contrast Imaging Protocol, and Analyses
Carotid ultrasonography and CEUS were performed using a highresolution ultrasound system (iU22; Philips Healthcare) equipped with a 9-3 MHZ linear transducer designed for contrast applications. The examination consisted initially of B-mode imaging, color Doppler ultrasound, and pulsed Doppler ultrasound of the common and internal carotid artery to determine topography and plaque severity. The operator then switched to a contrast-specific real-time low mechanicalindex (0.13) imaging modality (power modulation). SonoVue contrast agent (Bracco Diagnostics, Milan, Italy) was then injected via the antecubital vein as a bolus of 2 mL followed by a saline bolus of 5 mL. During this time, the carotid artery was reimaged longitudinally with a focus on stenosis. After the injection of ultrasound contrast agent, the lumen of the carotid artery was enhanced within 10 to 25 seconds. Power-modulation imaging is a pulse cancellation technique that transmits multiple pulses per image line, alternating full-amplitude pulses with half-amplitude pulses. Subtracting twice the return signal of the half-amplitude pulse from the return signal of the full-amplitude pulse cancels the linear response from the tissue, but not the nonlinear response from bubbles. To assess replenishment kinetics, microbubble destruction was achieved using 5 on-demand consecutive high-power frames (mechanical index, 1.0). Imaging then returned automatically to low-power, real-time scanning (mechanical index, 0.13). This switch to low mechanical index preserves the microbubbles that are destroyed by imaging at high mechanical index and therefore allows microbubble replenishment to be imaged in real-time. 13 A cineloop including images obtained at least 2 seconds before and 15 seconds after the appearance of the contrast agent in the lumen was acquired and digitally stored for subsequent analysis. If necessary, the bolus injection and the imaging sequences were repeated. IPN was graded semiquantitatively as absent (low-grade contrast enhancement [CE]: grade 0) or present in the plaque body (high-grade CE: grade 1). Images were graded by 2 independent investigators who were blinded to the patient's symptoms to evaluate interobserver consistency.
Immunohistochemical Analyses
At the time of carotid endarterectomy, the atherosclerotic plaques were immediately fixed in 10% buffered formalin and decalcified in the standard fashion. Specimens were transversally sectioned at 2-mm intervals. Each interval section was embedded in paraffin block, from which 5-µm sections were collected. Sections were then mounted on gelatin-coated slides and stained with the macrophage and endothelial cell markers, anti-CD68 (monoclonal antibody diluted 1/100; Dako), and anti-CD34 (monoclonal antibody diluted 1/500; Biocare Medical), respectively. A total of 8±2 slices covering the entire length of the plaque burden were analyzed per patient and per staining. All slices were scanned using Digital Image Hub 4.0 (Leica) for signal quantification. To evaluate CD68-staining intensity, computer-assisted planimetry (Tissue Image Analysis 2.0; Leica) was used. For each slice, the software identified the immunohistochemical staining to be quantified by minimizing background-staining artifacts using image filters ( Figure 1 ). The same filter was used for every patient. Macrophage staining was reported as a percentage of the plaque area (macrophage area/total plaque area, %CD68) and was averaged for all slices. Vasa-vasora were identified by CD34-positive immunostaining and were counted at a magnification of ×20 ( Figure 2 ). Each section was examined using a grid to manually measure the number of neovessels and ensure coverage of the entire area of the section. Neovascularization was then expressed as microvessel density (number of microvessels per mm 2 ) and averaged for all slices. Furthermore, to enhance the confidence in the validity of our observations, we performed a double CD34/CD31-staining in 10 randomly selected patients participating in our study (Data Supplement). Intraobserver and interobserver agreement were assessed for the quantification of microvessels. Finally, intraplaque hemorrhage was semiquantitatively assessed on histological samples.
Statistical Analyses
Continuous variables are presented as mean±SD or as median with interquartile range. Continuous variables were compared between 2 groups using the Mann-Whitney U test. The Spearman method was used to assess correlations between TBR and the histopathologic assessment of inflammation (CD68-staining) and the number of neovessels and between CD68-staining and the number of neovessels. To determine intra-and interobserver variability, CD34-stained images were reanalyzed separately by 2 observers. The interval between the initial analyses and those made for variability assessment were >3 months. Intra-and interobserver variability in quantitative parameters were assessed by computing intraclass correlation coefficients and by calculating the limits of agreement between measurements using Bland-Altman analysis. κstatistics were used to determine the levels of agreement between the visual grading scores of the CEUS readers. Kendall τ coefficient was used to measure the association between TBR and the CE-grade and between CE-grade and symptoms. A 2-sided value of P<0.05 was considered significant. All statistical analyses were performed using SPSS version 21.0 statistical software (Chicago, IL).
Results
Patient Variables
A total of 30 patients were included in this study; their characteristics are displayed in Table 1 . The mean age was 72±9 years, 22 patients were men, with 11 patients symptomatic. Symptoms consisted of transient ischemic attack for 4 patients and stroke for 7 patients. The mean delay between symptoms and surgery was 25 days (10-36 days).
Imaging Data Validated by Histology
As expected, we found a good correlation between the plaque 18 F-FDG-uptake and the number of macrophages ( Figure 3A , r=0.; P<0.001). 
P<0.001]).
We could find no correlation between vessel number and the calcium score (r=−0.24, P=0.21).
Inflammation and Neovascularization Are Not Systematically Associated Within the Plaque
As illustrated in Figures 4 and 5 Figure 6A ). Similarly, macrophage infiltration as determined by immunohistochemistry was comparable for grade 0 versus grade 1 CEUS plaques (CD68% 9.77±6.47 versus 12.38±9.5, respectively; P=0.59; Figure 6B ). Finally, neither 18F-FDG uptake nor CD68% were found to correlate with the degree of IPN ( Figure 7A and 7B) or the presence of hemorrhage (P=0.4 and P=0.23, respectively).
Features Associated With Symptoms
TBR was higher in symptomatic patients than in asymptomatic patients (1.97±0.28 versus 1.68±0.35; Figure 8A ; P=0.05). Similarly, macrophage infiltration was significantly higher in the carotid plaque of symptomatic patients than in the asymptomatic patients (14.16±6.2 versus 8.1±6.6 %CD68, respectively; Patients were categorized according to their inflammatory status based on the median TBR value (1.81). No association was found between inflammation and intraplaque neovascularization (Kendall coefficient τ: 0.0; P>0.99). TBR indicates target:background ratio; and CEUS, contrast-enhanced ultrasound. Table 3 ). Finally, we could identify no difference in the grading of carotid calcification (calcium score) according to the symptomatic status (P=0.98).
Intra-and Interobserver Agreement
We found an intraobserver reproducibility (intraclass correlation coefficients) of 0.77 with a bias of 80±74, and an interobserver reproducibility (intraclass correlation coefficients) of 0.83 with a bias of 93±81 for microvessel measurements. The concordance for the qualitative assessment of CEUS was determined by grading IPN by 2 different readers and by 1 reader at an interval of >3 months using CEUS cine-loops. The intraobserver agreement was 91% (κ=0.82), with an interobserver agreement for the same parameter of 77% (κ=0.51).
Discussion
Plaque inflammation and neovascularization are 2 recognized features of plaque vulnerability.
1 Here, we demonstrate that inflammation is not systematically associated with the degree of neovascularization within the plaque, suggesting a temporal separation of these processes. Furthermore, intraplaque inflammation was found to be associated with clinical symptoms whereas IPN was not.
Atherosclerosis is a chronic inflammatory disease characterized by lipid-containing lesions of large-and medium-sized arteries. Vasa vasora participate in the pathogenesis of the disease and proliferate to meet the nutritional needs of the artery's outer medial layer when metabolic demands exceed oxygen delivery from the luminal blood. Hypoxia is the most potent stimulus for angiogenesis, predominantly by its activation of the hypoxia-inducible factor/vascular endothelial growth factor pathway.
14 A molecular link exists between the expansion of adventitial vasa vasora, neointima formation, and atherosclerotic plaque development. Notably, their regression is accompanied by reduced plaque growth. 15 Neovessels may serve as a pathway for the recruitment of leucocytes to high-risk areas of plaque. Microvessel density has been shown to increase in inflamed lesions and correlates with plaque rupture. 16 Newly formed microvessels may promote intraplaque bleeding, which increases the levels of free cholesterol, and leads to rapid necrotic core expansion. This mechanism contributes to the vulnerability of the plaque. Fortunately, not all plaques will progress to destabilization and a substantial number will heal spontaneously. Some of the relevant mechanisms have been elucidated and promising strategies to stabilize atherosclerotic plaques are under development. 17 Atherosclerotic lesions evolve in successive phases during which inflammation and neovascularization are intertwined. 18, 19 However, it must be acknowledged that our ability to predict which plaques will progress to destabilization and cause an unstable syndrome such as transient ischemic attack, stroke, or acute coronary syndrome is currently very limited. Identifying vulnerable plaques before their rupture is the Holy Grail for clinicians. In this study, we identify patients with plaque inflammation without evidence of neovascularization, as well as the opposite. Our imaging findings have been validated by a systematic immunohistochemical evaluation covering the entire length of the surgical specimen.
Conflicting data for the temporal association of intraplaque inflammation and neovascularization currently exist in the literature. Some authors have found a weak correlation between the 2 processes, 20 which is contradicted by others. 21 We could find no correlation between either of these major determinants of plaque vulnerability, highlighting the practical challenges in defining imaging strategies with which to assess plaque vulnerability. Furthermore, plaque characteristics also seem to be dependent on general factors such as sex and age. 22 Several outstanding questions have yet to be satisfactorily addressed. For example, which plaque feature is the best predictor of a clinical event? When should we image, and should imaging be repeated? Can we base our imaging strategy on one plaque feature alone, and will we be in a position to predict the natural history of an atherosclerotic plaque? Ultimately, it is likely that imaging based on multiple structural and molecular targets will be required to identify atherosclerotic plaques at risk of rupture. Shear stress imaging, active calcification imaging ( 18 F-NaF), or other imaging tracers could also be helpful in achieving this goal. 23, 24 In previous studies to image vulnerable plaques, multimodality imaging has been investigated. In particular, the combined assessment of inflammation by 18 F-FDG PET-CT and neovascularization by dynamic contrast-enhanced magnetic resonance imaging has been evaluated in patients with carotid plaques, 20, 25, 26 with divergent results reported (inverse, weak, or a moderate correlation between inflammation and neovascularization). However, systematic histological validation was either lacking in those studies or limited to a comparatively small number of patients. 26 Furthermore, the same parameter for assessing neovascularization, κ trans , was used, which reflects microvascular flow and permeability rather than the total number of neovessels. The contrast agent used for CEUS evaluation in our study is purely intravascular and does not bridge the endothelial barrier. Consequently, this approach reveals the total number of neovessels in the plaque and not endothelial permeability, which is linked to inflammation. This approach therefore constitutes the major difference with dynamic contrast-enhanced magnetic resonance imaging, with either technique evaluating different tissue criteria (ie, the number of neovessels versus endothelial permeability). This may explain the discrepancies reported between results obtained using the 2 techniques and the absence of any correlation between inflammation and the total intraplaque number of vessels that we found in our study. The systematic immunohistological evaluation of the entire length of the surgical specimens of our patients confirmed our imaging findings and constitutes, to date, the largest series in which the 2 imaging techniques have been correlated with histology.
In our series and others, 22 ,27 a history of neurological symptoms is associated with increased plaque inflammation, whereas neovascularization is not. It is noteworthy that inflammation also seems to be associated with a higher risk of subsequent stroke, unlike neovascularization. 8, 28, 29 Collectively, an assessment of these data leads us to hypothesize that inflammation is probably the more useful parameter (than the presence of neovascularization) in discriminating patients at a high versus low risk for presenting acute syndromes. This hypothesis now warrants prospective validation. Interestingly, Staub et al 12 found an association with plaque enhancement, as assessed by CEUS, and a past history of cardiovascular events, a finding that we failed to repeat here. One explanation could be that our patients manifested more advanced disease. Like FDG-PET/ CT, the value of CEUS for predicting clinical events should also now be evaluated in prospective trials. We found an inverse correlation between CT calcium score and plaque inflammation, whereas no correlation was found between vessel number and the calcium score. It confirms that FDG is providing a measure of disease activity beyond measurement of plaque burden. Second, it is consistent with the hypothesis that extensive macroscopic calcification observed on CT is associated more with burnt-out stable disease than acute inflammation. Hence, this might have potential clinical utility. Finally, recent data suggest that emotional stressors could lead to cardiovascular disease by increasing arterial inflammation. 30 Whether stroke might induce a similar stress response and upregulation of plaque inflammation is unknown. Future studies are needed to confirm this hypothesis.
The possible limitations of this study are as follows. First, although the results of the present study are limited by its modest sample size, its strength lies in the simultaneous assessment of PET activity, IPN by CEUS, and histological validation. Nonetheless, subgroup analyses of asymptomatic versus symptomatic patients must be interpreted with caution. Second, we did not coregister imaging with histological data sets. Given the poor spatial resolution of FDG-PET, and the impossibility of coregistering CEUS with histology, we deliberately chose not to perform coregistration. We attempted to overcome this limitation by analyzing the total length of the surgical specimen to collect the entirety of the information contained within the plaque. Furthermore, inherent to the surgical technique, we could not quantify inflammation and neovascularization present in the adventitia by histology. Third, because histological analyses were mandatory for this study, we did not include patients with less advanced disease. Fourth, atherosclerotic plaques were not imaged by a high-resolution imaging modality like magnetic resonance imaging. Thus, components, including fibrous cap thickness, lipid-rich necrotic core, or intraplaque hemorrhage, that could be the physiopathological link between neoangiogenesis and inflammation were not evaluated. Finally, no scan-rescan reproducibility was performed.
Conclusions
Inflammation and neovascularization are not systematically associated in the carotid plaques of patients suggesting a temporal separation of these processes. Inflammation seems also more pronounced when symptoms are present, whereas neovascularization seems not. This study highlights the practical challenges in defining imaging strategies with which to assess plaque vulnerability.
CLINICAL PERSPECTIVE
In the majority of cases, acute vascular events are caused by the disruption of a vulnerable atherosclerotic plaque. Compared with stable lesions, rupture-prone or vulnerable plaques typically exhibit inflammation and intraplaque neovascularization. The ability to identify which atherosclerotic plaques are at risk of rupture would constitute a major advance in the management of atherosclerotic disease. The results of the study provide evidence that inflammatory state and intraplaque neovascularization vary overtime and are not systematically associated within the plaque. In this study, history of neurological symptoms is associated with increased plaque inflammation, whereas neovascularization seems not. On which imaged-feature should we focus to predict clinical events? Must imaging be repeated? These questions are, as yet, unanswered. The natural histories of plaques, and their healing capacities, must be better understood before noninvasive imaging can become a useful tool for predicting clinical events. Multicenter studies assessing the value of inflammation-based or neovascularization-based imaging to predict clinical events such as stroke or acute cardiac events are needed. For noninvasive techniques to find clinical applications they will have to identify high-risk patients with a several-fold improvement in predictive value versus the currently available clinical approach.
